Literature DB >> 9288773

Regulation of mevalonate synthesis in rat mammary glands by dietary n-3 and n-6 polyunsaturated fatty acids.

A El-Sohemy1, M C Archer.   

Abstract

It is well established that dietary n-6 polyunsaturated fatty acids (PU-FAs) enhance rat mammary tumor development whereas n-3 PUFAs inhibit it, yet the mechanisms are unclear. The objective of this study was to investigate a mechanism by which n-3 and n-6 PUFAs could modulate mammary carcinogenesis. Female Sprague Dawley rats were fed diets containing either menhaden (n-3) or safflower oil (n-6) in a 7% fat diet for 1 week. In comparison to the n-6 diet, the n-3 diet significantly reduced the activity and levels of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase in mammary glands, thereby suppressing the formation of mevalonate. In addition to being essential for cholesterol biosynthesis, mevalonate is also required for DNA synthesis and may be involved in malignant transformation. Serum cholesterol was lower in the n-3 group than in the n-6 group (1.91 +/- 0.18 versus 2.61 +/- 0.37 mM; P < 0.01). Extrahepatic tissues meet most of their cholesterol requirements from circulating cholesterol, and the internalized cholesterol down-regulates HMG-CoA reductase. Thus, the concomitant decrease in serum cholesterol and mammary gland HMG-CoA reductase levels suggests that changes in circulating cholesterol levels do not solely determine the activity of extrahepatic reductase. We conclude that the mevalonate pathway may be a mechanism through which different types of dietary fat modulate breast cancer development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9288773

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Effects of n-3 and n-6 polyunsaturated fatty acids on 3-hydroxy-3-methylglutaryl-CoA reductase in liver and mammary glands of low density lipoprotein-receptor knockout mice.

Authors:  A El-Sohemy; M C Archer
Journal:  Lipids       Date:  1999       Impact factor: 1.880

2.  Regulation of mevalonate synthesis in low density lipoprotein receptor knockout mice fed n-3 or n-6 polyunsaturated fatty acids.

Authors:  A El-Sohemy; M C Archer
Journal:  Lipids       Date:  1999-10       Impact factor: 1.880

3.  Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis.

Authors:  Mozaffarul Islam; Smita Sharma; Bhavna Kumar; Theodoros N Teknos
Journal:  Oral Oncol       Date:  2013-05-04       Impact factor: 5.337

Review 4.  Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management.

Authors:  Mohd Waiz; Sahir Sultan Alvi; M Salman Khan
Journal:  EXCLI J       Date:  2022-01-05       Impact factor: 4.068

Review 5.  Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2008-10-15       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.